Skip to main content

Peer Review reports

From: Three-arm phase II trial comparing camrelizumab plus chemotherapy versus camrelizumab plus chemoradiation versus chemoradiation as preoperative treatment for locally advanced esophageal squamous cell carcinoma (NICE-2 Study)

Original Submission
15 Mar 2022 Submitted Original manuscript
15 Apr 2022 Author responded Author comments - Yang Yang
Resubmission - Version 2
15 Apr 2022 Submitted Manuscript version 2
19 Apr 2022 Editorially accepted
6 May 2022 Article published 10.1186/s12885-022-09573-6

You can find further information about peer review here.

Back to article page